# Harnessing the Disease Signatures From Endometrium and Menstrual Blood to Identify Avenues for the Treatment of Chronic Conditions Such as Endometriosis and Related Pathologies: This is an Observational Study Aimed at Shedding Light on Women's Health

> **NCT06990971** · — · NOT_YET_RECRUITING · sponsor: **Cycle Therapeutics Ltd** · enrollment: 200 (estimated)

## Conditions studied

- Endometriosis
- Infertility
- Endometrial Cancer
- Adenomyosis, Endometriosis

## Interventions

- **OTHER:** No Intervention: Observational Cohort

## Key facts

- **NCT ID:** NCT06990971
- **Lead sponsor:** Cycle Therapeutics Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-06-01
- **Primary completion:** 2029-05-31
- **Final completion:** 2029-05-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06990971

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06990971, "Harnessing the Disease Signatures From Endometrium and Menstrual Blood to Identify Avenues for the Treatment of Chronic Conditions Such as Endometriosis and Related Pathologies: This is an Observational Study Aimed at Shedding Light on Women's Health". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06990971. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*